This CME conference will offer a comprehensive summary of new medications and clinical data pertaining to the management and treatment of atherosclerosis.
San Diego Marriott La Jolla
4240 La Jolla Village Drive
La Jolla, California 92037
Discounted rooms will be available
Atherosclerotic cardiovascular disease is a common problem which may begin early in life and progress as a person ages. The atherosclerotic condition involves lipid deposition of the arterial wall, which involves the immune system, inflammatory mediators, and the endothelial system. Over time, if developing atherosclerosis is left untreated, it may be progressive and can result in several dangerous and life-threatening cardiovascular conditions including myocardial infarction, carotid artery disease and stroke, among others. While atherosclerosis can often be prevented through good lifestyle choices including proper diet and exercise, a number of therapeutic options are available for patients where lifestyle changes may not be enough.
Over the past several years there has been a substantial increase of clinical trials specifically dedicated to the management and treatment of atherosclerosis and underlying risk factors. These studies have generated comprehensive data on a large number of randomized patients and have led to new indications for medical therapies. Clinicians need to be familiar with these evolving clinical diagnoses and novel therapeutic options for their patients. The Scripps Cardiovascular Atherosclerosis conference is designed to offer a comprehensive summary of these new treatment options as well as to promote clinical awareness regarding prudent lifestyle and dietary choices to improve patient outcomes.
After attending this live activity, participants should be able to:
- Identify cardiac risk factors and estimation of patients’ clinical risk.
- Explain mechanism and indication of PCSK9 inhibitors and omega 3 fish oil.
- Summarize mechanism and indication of SGL2 inhibitors as well as GLP1 agonists’ mechanisms of action and cite indications for use.
- Describe the cardiovascular benefits associated with diet and exercise modifications.
- Assess cardiac CT scoring and utility of coronary CTA.
- Illustrate polygenetic risk scoring in primary prevention of atherosclerotic cardiovascular disease.
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses and Nurse Practitioners
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.
For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.
The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.
This course may be supported, in part, by educational grants from industry. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, a complete list of commercial support received will be provided to all learners who participate in the continuing education activity. For more information: www.accme.org/standards.
Cultural & Linguistic Competency and Implicit Bias
This activity is designed to include curriculum addressing the topics of cultural and linguistic competency (CLC) and implicit bias (IB) in compliance with California Business and Professions (B&P) Code Section 2190. All those involved in the planning and execution of this activity have been asked to identify and discuss issues relevant to the topics being covered. In addition, a variety of resources are available that address cultural and linguistic competency and implicit bias. A resource document can be downloaded from the Conference Details section above.
Date and time
Sat, May 20, 2023
7 am - 5 pm